Top View
- Sustained Release Talazoparib Implants for Localized Treatment of BRCA1-Deficient Breast Cancer Jodi E
- NCCN: Genetic/Familial High-Risk Assessment: Breast and Ovarian
- Ion Ampliseq BRCA1 and BRCA2 Panel a Community Panel Designed with Input from Leading Researchers
- Therapeutic Targeting of BRCA1 and TP53 Mutant Breast Cancer Through Mutant P53 Reactivation
- BRCA1 and BRCA2 Genes Mutations Among High Risk Breast Cancer
- A Family Pedigree of Malignancies Associated with BRCA1 Pathogenic Variants: a Reflection of the State of Art in China Wenhui Li, Lei Li* and Ming Wu
- Estrogen Promotes Estrogen Receptor Negative BRCA1-Deficient Tumor
- Prognostic Impact of BRCA1 and BRCA2 Mutations on Long-Term Survival Outcomes in Egyptian Female Breast Cancer Patients
- BRCA1 Expression Serves a Role in Vincristine Resistance in Colon Cancer Cells
- The P53 Mutational Spectrum Associated with BRCA1 Mutant Ovarian Cancer1
- Precision Medicine and Genetic Counseling : Is Yes Always the Correct Answer? Beverly M
- Biomimetic Synthesis of Silver Nanoparticles for Breast Cancer
- Downregulation of BRCA1-BRCA2-Containing Complex Subunit 3 Sensitizes Glioma Cells to Temozolomide
- Management of Women with a Genetic Predisposition to Gynaecological Cancers
- Molecular Testing for the BRCA1 and BRCA2 Ashkenazi Jewish Founder Mutations: a Report on the College of American Pathologists Proficiency Testing Surveys
- (HBOC) the Risk for Cancer Associated with BRCA1 and BRCA2 Gene
- Mouse Models of BRCA1 and BRCA2 Deficiency
- BRCA1 and Cell Signaling
- Clinical Follow-Up and Breast and Ovarian Cancer Screening of True BRCA1/2 Noncarriers: a Qualitative Investigation
- 2.04.02 Genetic Testing for BRCA1 Or BRCA2 for Hereditary Breast/Ovarian Cancer Syndrome and Other High-Risk Cancers Page 2 of 37
- Functional Characterization of a Novel BRCA1-Null Ovarian Cancer Cell Line in Response to Ionizing Radiation
- BRCA1 and BRCA2 Genetic Testing – Medicare Advantage Policy
- Consensus Guideline on Genetic Testing for Hereditary Breast Cancer
- Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer US Preventive Services Task Force Recommendation Statement
- BRCA1 Mrna Expression Modifies the Effect of T Cell Activation Score
- Genetically Defined Syngeneic Mouse Models of Ovarian Cancer As Tools for the Discovery of Combination Immunotherapy
- Functional and Mutational Landscapes of BRCA1 for Homology-Directed
- Which BRCA Genetic Testing Programs Are Ready for Implementation in Health Care? a Systematic Review of Economic Evaluations
- Medical Necessity Guidelines: Genetic Testing: BRCA-Related Breast And/Or Ovarian Cancer Syndrome Effective: October 21, 2020
- Understanding Your Positive BRCA1 Genetic Test Result Information for Patients with a Pathogenic Mutation Or Variant, Likely Pathogenic
- BRCA1 Shifts P53-Mediated Cellular Outcomes Towards Irreversible Growth Arrest
- BRCA1 and BRCA2 For
- Breast Cancer Stem Cells: a Moving Target for Cancer Nanomedicine
- Molecular Genetic Characterization of BRCA1- and 5/?CA2-Linked Hereditary Ovarian Cancers1
- Knowledge, Attitudes, and Utilization of BRCA Testing Among Obstetricians and Gynecologists
- Breast Cancer Mortality Among Women with a BRCA1 Or BRCA2 Mutation in a Magnetic Resonance Imaging Plus Mammography Screening Program
- Prevalence of Tumor BRCA1 and BRCA2 Dysfunction in Unselected Patients with Ovarian Cancer Roshni D
- BRCA2 and P53 Mutations in Primary Breast Cancer in Relation to Genetic Instability1
- Gynecologic Oncologist, OB/GYN Or General Surgeon
- Pathological Features and BRCA1 Mutation Screening in Premenopausal Breast Cancer Patients1
- Novel and Recurrent BRCA1/BRCA2
- Male Breast Cancer in BRCA1 and BRCA2 Mutation Carriers: Pathology Data from the Consortium of Investigators of Modifiers of BRCA1/2
- Genetic Testing for Hereditary Cancer – Commercial Medical Policy
- Mutation of a Single Allele of the Cancer Susceptibility Gene BRCA1 Leads to Genomic Instability in Human Breast Epithelial Cells
- The Clinical and Pathological Profile of BRCA1 Gene Methylated
- Breast Cancer Genes, Risk Assessment and Screening
- Genetic Testing for BRCA1 Or BRCA2 for Hereditary Breast-Ovarian
- Hereditary Cancer Clinic BRCA1 Mutation Positive Guidelines
- Pathology of Hereditary Breast Cancer
- Molecular Characteristics of Breast Cancer According to Clinicopathological Factors
- TNBC: Potential Targeting of Multiple Receptors for a Therapeutic Breakthrough, Nanomedicine, and Immunotherapy
- Early Cancer Diagnoses Through BRCA1/2 Screening of Unselected Adult Biobank Participants
- A Beginner's Guide to BRCA1 and BRCA2
- Pathology and Gene Expression of Hereditary Breast Tumors Associated with BRCA1, BRCA2 and CHEK2 Gene Mutations
- DNA Damage Repair As a Target in Pancreatic Cancer: State-Of- The-Art and Future Perspectives Gut: First Published As 10.1136/Gutjnl-2019-319984 on 27 August 2020
- Genetic Testing and Counseling of a Recipient After Bone Marrow Transplant from a Sibling Harboring a Germline BRCA1 Pathogenic Mutation
- Genetic Counseling, Polymorphisms and Breast Cancer Kleber Santiago Freitas E Silva*